Genomic information at the service of human health and its environment
Deeplex® Myc-TB: Pursue the global deployment of the innovative solution for predicting antibiotic resistance in tuberculosis
GenoScreen and ScienceVision announce an agreement to commercialize the Deeplex® Myc-TB test in Malaysia, Myanmar and Brunei.
Tuberculosis has been a major scourge since antiquity. The fight against this disease requires ever more efficient technologies. GenoScreen, a French biotech company, has recently developed a new weapon for predicting antibiotic resistance in the germs responsible for this disease. This new test,...
The innovative Deeplex® Myc-TB test for antibiotic resistance prediction in tuberculosis, created by GenoScreen, has been evaluated by an Indian research team. By testing approximately 40 clinical samples, this study validates the use of Deeplex® Myc-TB, by demonstrating its usability in hospital...
From June 27 to 30, 2021
ESM 41st Annual Meeting
Meet us at the 41st Annual Meeting of the European Society of Mycobacteriology from June 27 to 30, 2021 in Tirana, Albania. More information
From October 5 to 7, 2021
IN-COSMETICS GLOBAL, Barcelona, Spain
Meet us at IN-COSMETICS GLOBAL from October 5 to 7, 2021 in Barcelona, Spain. More information